Cargando…
Expamers: a new technology to control T cell activation
T cell activation is a cornerstone in manufacturing of T cell-based therapies, and precise control over T cell activation is important in the development of the next generation T-cell based therapeutics. This need cannot be fulfilled by currently available methods for T cell stimulation, in particul...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575567/ https://www.ncbi.nlm.nih.gov/pubmed/33082362 http://dx.doi.org/10.1038/s41598-020-74595-8 |
_version_ | 1783597834394664960 |
---|---|
author | Poltorak, Mateusz P. Graef, Patricia Tschulik, Claudia Wagner, Michaela Cletiu, Vlad Dreher, Stefan Borjan, Bojana Fraessle, Simon P. Effenberger, Manuel Turk, Martin Busch, Dirk H. Plitzko, Juergen Kugler, David G. Ragan, Seamus Schmidt, Thomas Stemberger, Christian Germeroth, Lothar |
author_facet | Poltorak, Mateusz P. Graef, Patricia Tschulik, Claudia Wagner, Michaela Cletiu, Vlad Dreher, Stefan Borjan, Bojana Fraessle, Simon P. Effenberger, Manuel Turk, Martin Busch, Dirk H. Plitzko, Juergen Kugler, David G. Ragan, Seamus Schmidt, Thomas Stemberger, Christian Germeroth, Lothar |
author_sort | Poltorak, Mateusz P. |
collection | PubMed |
description | T cell activation is a cornerstone in manufacturing of T cell-based therapies, and precise control over T cell activation is important in the development of the next generation T-cell based therapeutics. This need cannot be fulfilled by currently available methods for T cell stimulation, in particular not in a time dependent manner. Here, we describe a modular activation reagent called Expamers, which addresses these limitations. Expamers are versatile stimuli that are intended for research and clinical use. They are readily soluble and can be rapidly bound and removed from the cell surface, allowing nearly instantaneous initiation and termination of activation signal, respectively. Hence, Expamers enable precise regulation of T cell stimulation duration and provide promise of control over T cell profiles in future products. Expamers can be easily adopted to different T cell production formats and have the potential to increase efficacy of T cell immunotherapeutics. |
format | Online Article Text |
id | pubmed-7575567 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-75755672020-10-21 Expamers: a new technology to control T cell activation Poltorak, Mateusz P. Graef, Patricia Tschulik, Claudia Wagner, Michaela Cletiu, Vlad Dreher, Stefan Borjan, Bojana Fraessle, Simon P. Effenberger, Manuel Turk, Martin Busch, Dirk H. Plitzko, Juergen Kugler, David G. Ragan, Seamus Schmidt, Thomas Stemberger, Christian Germeroth, Lothar Sci Rep Article T cell activation is a cornerstone in manufacturing of T cell-based therapies, and precise control over T cell activation is important in the development of the next generation T-cell based therapeutics. This need cannot be fulfilled by currently available methods for T cell stimulation, in particular not in a time dependent manner. Here, we describe a modular activation reagent called Expamers, which addresses these limitations. Expamers are versatile stimuli that are intended for research and clinical use. They are readily soluble and can be rapidly bound and removed from the cell surface, allowing nearly instantaneous initiation and termination of activation signal, respectively. Hence, Expamers enable precise regulation of T cell stimulation duration and provide promise of control over T cell profiles in future products. Expamers can be easily adopted to different T cell production formats and have the potential to increase efficacy of T cell immunotherapeutics. Nature Publishing Group UK 2020-10-20 /pmc/articles/PMC7575567/ /pubmed/33082362 http://dx.doi.org/10.1038/s41598-020-74595-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Poltorak, Mateusz P. Graef, Patricia Tschulik, Claudia Wagner, Michaela Cletiu, Vlad Dreher, Stefan Borjan, Bojana Fraessle, Simon P. Effenberger, Manuel Turk, Martin Busch, Dirk H. Plitzko, Juergen Kugler, David G. Ragan, Seamus Schmidt, Thomas Stemberger, Christian Germeroth, Lothar Expamers: a new technology to control T cell activation |
title | Expamers: a new technology to control T cell activation |
title_full | Expamers: a new technology to control T cell activation |
title_fullStr | Expamers: a new technology to control T cell activation |
title_full_unstemmed | Expamers: a new technology to control T cell activation |
title_short | Expamers: a new technology to control T cell activation |
title_sort | expamers: a new technology to control t cell activation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575567/ https://www.ncbi.nlm.nih.gov/pubmed/33082362 http://dx.doi.org/10.1038/s41598-020-74595-8 |
work_keys_str_mv | AT poltorakmateuszp expamersanewtechnologytocontroltcellactivation AT graefpatricia expamersanewtechnologytocontroltcellactivation AT tschulikclaudia expamersanewtechnologytocontroltcellactivation AT wagnermichaela expamersanewtechnologytocontroltcellactivation AT cletiuvlad expamersanewtechnologytocontroltcellactivation AT dreherstefan expamersanewtechnologytocontroltcellactivation AT borjanbojana expamersanewtechnologytocontroltcellactivation AT fraesslesimonp expamersanewtechnologytocontroltcellactivation AT effenbergermanuel expamersanewtechnologytocontroltcellactivation AT turkmartin expamersanewtechnologytocontroltcellactivation AT buschdirkh expamersanewtechnologytocontroltcellactivation AT plitzkojuergen expamersanewtechnologytocontroltcellactivation AT kuglerdavidg expamersanewtechnologytocontroltcellactivation AT raganseamus expamersanewtechnologytocontroltcellactivation AT schmidtthomas expamersanewtechnologytocontroltcellactivation AT stembergerchristian expamersanewtechnologytocontroltcellactivation AT germerothlothar expamersanewtechnologytocontroltcellactivation |